JANEEN CONSTANTINE: Open Payments
NPI 1720198302 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$685 in 22 payments from 8 companies in 2025. Trend: 2023 $184 · 2024 $1,026 · 2025 $685
Food & beverage: $685
| Company | Payments | Amount |
|---|---|---|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 10 | $248 |
| Amgen Inc. | 4 | $148 |
| SCPHARMACEUTICALS INC. | 1 | $116 |
| Novo Nordisk Inc | 2 | $54 |
| PFIZER INC. | 2 | $44 |
| Boston Scientific Corporation | 1 | $31 |
| Abbott Laboratories | 1 | $27 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
Products named: LifeVest, REPATHA, FUROSCIX, ELIQUIS, Upsylon, Wegovy, AVEIR.
Industry payments across DC — which companies pay providers there.
